nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—UGT2B7—Ezetimibe—atherosclerosis	0.194	0.252	CbGbCtD
Silodosin—UGT2B7—Simvastatin—atherosclerosis	0.181	0.234	CbGbCtD
Silodosin—UGT2B7—Lovastatin—atherosclerosis	0.177	0.229	CbGbCtD
Silodosin—ABCB1—Ezetimibe—atherosclerosis	0.0333	0.0432	CbGbCtD
Silodosin—ABCB1—Simvastatin—atherosclerosis	0.031	0.0401	CbGbCtD
Silodosin—ABCB1—Pravastatin—atherosclerosis	0.0303	0.0393	CbGbCtD
Silodosin—ABCB1—Lovastatin—atherosclerosis	0.0303	0.0393	CbGbCtD
Silodosin—CYP3A4—Rosuvastatin—atherosclerosis	0.02	0.0259	CbGbCtD
Silodosin—CYP3A4—Ezetimibe—atherosclerosis	0.02	0.0259	CbGbCtD
Silodosin—CYP3A4—Simvastatin—atherosclerosis	0.0186	0.024	CbGbCtD
Silodosin—CYP3A4—Lovastatin—atherosclerosis	0.0182	0.0235	CbGbCtD
Silodosin—CYP3A4—Pravastatin—atherosclerosis	0.0182	0.0235	CbGbCtD
Silodosin—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00183	0.0168	CcSEcCtD
Silodosin—Vascular purpura—Lovastatin—atherosclerosis	0.00178	0.0164	CcSEcCtD
Silodosin—Hepatic function abnormal—Simvastatin—atherosclerosis	0.00171	0.0157	CcSEcCtD
Silodosin—Breast disorder—Rosuvastatin—atherosclerosis	0.0017	0.0157	CcSEcCtD
Silodosin—Vascular purpura—Simvastatin—atherosclerosis	0.00167	0.0154	CcSEcCtD
Silodosin—Purpura—Lovastatin—atherosclerosis	0.00165	0.0152	CcSEcCtD
Silodosin—Hepatic function abnormal—Niacin—atherosclerosis	0.00157	0.0144	CcSEcCtD
Silodosin—Purpura—Simvastatin—atherosclerosis	0.00155	0.0143	CcSEcCtD
Silodosin—Hepatic function abnormal—Pravastatin—atherosclerosis	0.00154	0.0142	CcSEcCtD
Silodosin—Vascular purpura—Pravastatin—atherosclerosis	0.00151	0.0139	CcSEcCtD
Silodosin—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00144	0.0133	CcSEcCtD
Silodosin—Jaundice—Rosuvastatin—atherosclerosis	0.00141	0.013	CcSEcCtD
Silodosin—Breast disorder—Ezetimibe—atherosclerosis	0.00141	0.013	CcSEcCtD
Silodosin—Purpura—Pravastatin—atherosclerosis	0.0014	0.0129	CcSEcCtD
Silodosin—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0014	0.0129	CcSEcCtD
Silodosin—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.00137	0.0126	CcSEcCtD
Silodosin—Sinusitis—Rosuvastatin—atherosclerosis	0.00136	0.0125	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00136	0.0125	CcSEcCtD
Silodosin—Erectile dysfunction—Lovastatin—atherosclerosis	0.00127	0.0117	CcSEcCtD
Silodosin—Liver function test abnormal—Niacin—atherosclerosis	0.00126	0.0117	CcSEcCtD
Silodosin—Orthostatic hypotension—Niacin—atherosclerosis	0.00125	0.0115	CcSEcCtD
Silodosin—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00125	0.0115	CcSEcCtD
Silodosin—Liver function test abnormal—Pravastatin—atherosclerosis	0.00125	0.0115	CcSEcCtD
Silodosin—Nasopharyngitis—Pravastatin—atherosclerosis	0.00121	0.0111	CcSEcCtD
Silodosin—Erectile dysfunction—Simvastatin—atherosclerosis	0.00119	0.0109	CcSEcCtD
Silodosin—Jaundice—Ezetimibe—atherosclerosis	0.00118	0.0108	CcSEcCtD
Silodosin—Sinusitis—Lovastatin—atherosclerosis	0.00115	0.0106	CcSEcCtD
Silodosin—Mental disorder—Rosuvastatin—atherosclerosis	0.00114	0.0105	CcSEcCtD
Silodosin—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.00114	0.0105	CcSEcCtD
Silodosin—Sinusitis—Ezetimibe—atherosclerosis	0.00113	0.0104	CcSEcCtD
Silodosin—Jaundice—Simvastatin—atherosclerosis	0.00112	0.0103	CcSEcCtD
Silodosin—Erectile dysfunction—Niacin—atherosclerosis	0.00109	0.01	CcSEcCtD
Silodosin—Sinusitis—Simvastatin—atherosclerosis	0.00108	0.00994	CcSEcCtD
Silodosin—Erectile dysfunction—Pravastatin—atherosclerosis	0.00107	0.00989	CcSEcCtD
Silodosin—Jaundice—Niacin—atherosclerosis	0.00103	0.00948	CcSEcCtD
Silodosin—Jaundice—Pravastatin—atherosclerosis	0.00101	0.00934	CcSEcCtD
Silodosin—Angiopathy—Ezetimibe—atherosclerosis	0.000982	0.00905	CcSEcCtD
Silodosin—Immune system disorder—Ezetimibe—atherosclerosis	0.000978	0.00901	CcSEcCtD
Silodosin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000975	0.00899	CcSEcCtD
Silodosin—Sinusitis—Pravastatin—atherosclerosis	0.000975	0.00899	CcSEcCtD
Silodosin—Mental disorder—Ezetimibe—atherosclerosis	0.000948	0.00874	CcSEcCtD
Silodosin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000907	0.00836	CcSEcCtD
Silodosin—Mental disorder—Simvastatin—atherosclerosis	0.000904	0.00833	CcSEcCtD
Silodosin—Cardiac disorder—Pravastatin—atherosclerosis	0.000866	0.00798	CcSEcCtD
Silodosin—Angiopathy—Niacin—atherosclerosis	0.00086	0.00792	CcSEcCtD
Silodosin—Insomnia—Rosuvastatin—atherosclerosis	0.000837	0.00771	CcSEcCtD
Silodosin—Palpitations—Ezetimibe—atherosclerosis	0.000833	0.00767	CcSEcCtD
Silodosin—Dry mouth—Lovastatin—atherosclerosis	0.0008	0.00737	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000797	0.00734	CcSEcCtD
Silodosin—Dry mouth—Ezetimibe—atherosclerosis	0.000784	0.00723	CcSEcCtD
Silodosin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000756	0.00697	CcSEcCtD
Silodosin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000754	0.00695	CcSEcCtD
Silodosin—Skin disorder—Ezetimibe—atherosclerosis	0.000747	0.00688	CcSEcCtD
Silodosin—Syncope—Niacin—atherosclerosis	0.00074	0.00682	CcSEcCtD
Silodosin—Urticaria—Rosuvastatin—atherosclerosis	0.000735	0.00677	CcSEcCtD
Silodosin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000731	0.00674	CcSEcCtD
Silodosin—Palpitations—Niacin—atherosclerosis	0.000729	0.00672	CcSEcCtD
Silodosin—Loss of consciousness—Niacin—atherosclerosis	0.000725	0.00668	CcSEcCtD
Silodosin—Insomnia—Lovastatin—atherosclerosis	0.000709	0.00653	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000698	0.00643	CcSEcCtD
Silodosin—Insomnia—Ezetimibe—atherosclerosis	0.000695	0.00641	CcSEcCtD
Silodosin—Dry mouth—Niacin—atherosclerosis	0.000687	0.00633	CcSEcCtD
Silodosin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000664	0.00612	CcSEcCtD
Silodosin—Asthenia—Rosuvastatin—atherosclerosis	0.000664	0.00612	CcSEcCtD
Silodosin—Insomnia—Simvastatin—atherosclerosis	0.000663	0.00611	CcSEcCtD
Silodosin—Shock—Niacin—atherosclerosis	0.000662	0.0061	CcSEcCtD
Silodosin—Tachycardia—Niacin—atherosclerosis	0.000657	0.00606	CcSEcCtD
Silodosin—Pruritus—Rosuvastatin—atherosclerosis	0.000654	0.00603	CcSEcCtD
Silodosin—Skin disorder—Niacin—atherosclerosis	0.000654	0.00603	CcSEcCtD
Silodosin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000641	0.00591	CcSEcCtD
Silodosin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000633	0.00583	CcSEcCtD
Silodosin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000633	0.00583	CcSEcCtD
Silodosin—Hypotension—Niacin—atherosclerosis	0.000629	0.0058	CcSEcCtD
Silodosin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000629	0.00579	CcSEcCtD
Silodosin—Urticaria—Lovastatin—atherosclerosis	0.000623	0.00574	CcSEcCtD
Silodosin—Abdominal pain—Lovastatin—atherosclerosis	0.00062	0.00571	CcSEcCtD
Silodosin—Dizziness—Rosuvastatin—atherosclerosis	0.000612	0.00564	CcSEcCtD
Silodosin—Urticaria—Ezetimibe—atherosclerosis	0.000611	0.00563	CcSEcCtD
Silodosin—Insomnia—Niacin—atherosclerosis	0.000609	0.00561	CcSEcCtD
Silodosin—Abdominal pain—Ezetimibe—atherosclerosis	0.000608	0.0056	CcSEcCtD
Silodosin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0006	0.00553	CcSEcCtD
Silodosin—Insomnia—Pravastatin—atherosclerosis	0.0006	0.00552	CcSEcCtD
Silodosin—Rash—Rosuvastatin—atherosclerosis	0.000583	0.00537	CcSEcCtD
Silodosin—Dermatitis—Rosuvastatin—atherosclerosis	0.000583	0.00537	CcSEcCtD
Silodosin—Urticaria—Simvastatin—atherosclerosis	0.000583	0.00537	CcSEcCtD
Silodosin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000581	0.00536	CcSEcCtD
Silodosin—Abdominal pain—Simvastatin—atherosclerosis	0.00058	0.00534	CcSEcCtD
Silodosin—Headache—Rosuvastatin—atherosclerosis	0.00058	0.00534	CcSEcCtD
Silodosin—Asthenia—Lovastatin—atherosclerosis	0.000562	0.00518	CcSEcCtD
Silodosin—Pruritus—Lovastatin—atherosclerosis	0.000555	0.00511	CcSEcCtD
Silodosin—Asthenia—Ezetimibe—atherosclerosis	0.000552	0.00508	CcSEcCtD
Silodosin—Gastrointestinal pain—Niacin—atherosclerosis	0.000551	0.00507	CcSEcCtD
Silodosin—Nausea—Rosuvastatin—atherosclerosis	0.000549	0.00506	CcSEcCtD
Silodosin—Pruritus—Ezetimibe—atherosclerosis	0.000544	0.00501	CcSEcCtD
Silodosin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000542	0.005	CcSEcCtD
Silodosin—Diarrhoea—Lovastatin—atherosclerosis	0.000536	0.00494	CcSEcCtD
Silodosin—Urticaria—Niacin—atherosclerosis	0.000535	0.00493	CcSEcCtD
Silodosin—Abdominal pain—Niacin—atherosclerosis	0.000532	0.0049	CcSEcCtD
Silodosin—Urticaria—Pravastatin—atherosclerosis	0.000527	0.00485	CcSEcCtD
Silodosin—Asthenia—Simvastatin—atherosclerosis	0.000526	0.00485	CcSEcCtD
Silodosin—Diarrhoea—Ezetimibe—atherosclerosis	0.000526	0.00485	CcSEcCtD
Silodosin—Abdominal pain—Pravastatin—atherosclerosis	0.000524	0.00483	CcSEcCtD
Silodosin—Pruritus—Simvastatin—atherosclerosis	0.000519	0.00478	CcSEcCtD
Silodosin—Dizziness—Lovastatin—atherosclerosis	0.000518	0.00478	CcSEcCtD
Silodosin—Dizziness—Ezetimibe—atherosclerosis	0.000508	0.00469	CcSEcCtD
Silodosin—Diarrhoea—Simvastatin—atherosclerosis	0.000502	0.00462	CcSEcCtD
Silodosin—Rash—Lovastatin—atherosclerosis	0.000494	0.00455	CcSEcCtD
Silodosin—Dermatitis—Lovastatin—atherosclerosis	0.000494	0.00455	CcSEcCtD
Silodosin—Headache—Lovastatin—atherosclerosis	0.000491	0.00453	CcSEcCtD
Silodosin—Dizziness—Simvastatin—atherosclerosis	0.000485	0.00447	CcSEcCtD
Silodosin—Rash—Ezetimibe—atherosclerosis	0.000485	0.00447	CcSEcCtD
Silodosin—Dermatitis—Ezetimibe—atherosclerosis	0.000484	0.00446	CcSEcCtD
Silodosin—Asthenia—Niacin—atherosclerosis	0.000483	0.00445	CcSEcCtD
Silodosin—Headache—Ezetimibe—atherosclerosis	0.000482	0.00444	CcSEcCtD
Silodosin—Pruritus—Niacin—atherosclerosis	0.000476	0.00439	CcSEcCtD
Silodosin—Asthenia—Pravastatin—atherosclerosis	0.000476	0.00438	CcSEcCtD
Silodosin—Pruritus—Pravastatin—atherosclerosis	0.000469	0.00432	CcSEcCtD
Silodosin—Nausea—Lovastatin—atherosclerosis	0.000466	0.00429	CcSEcCtD
Silodosin—Rash—Simvastatin—atherosclerosis	0.000462	0.00426	CcSEcCtD
Silodosin—Dermatitis—Simvastatin—atherosclerosis	0.000462	0.00426	CcSEcCtD
Silodosin—Diarrhoea—Niacin—atherosclerosis	0.000461	0.00424	CcSEcCtD
Silodosin—Headache—Simvastatin—atherosclerosis	0.000459	0.00423	CcSEcCtD
Silodosin—Nausea—Ezetimibe—atherosclerosis	0.000457	0.00421	CcSEcCtD
Silodosin—Diarrhoea—Pravastatin—atherosclerosis	0.000454	0.00418	CcSEcCtD
Silodosin—Dizziness—Niacin—atherosclerosis	0.000445	0.0041	CcSEcCtD
Silodosin—Dizziness—Pravastatin—atherosclerosis	0.000438	0.00404	CcSEcCtD
Silodosin—Nausea—Simvastatin—atherosclerosis	0.000436	0.00401	CcSEcCtD
Silodosin—Rash—Niacin—atherosclerosis	0.000425	0.00391	CcSEcCtD
Silodosin—Dermatitis—Niacin—atherosclerosis	0.000424	0.00391	CcSEcCtD
Silodosin—Headache—Niacin—atherosclerosis	0.000422	0.00389	CcSEcCtD
Silodosin—Rash—Pravastatin—atherosclerosis	0.000418	0.00385	CcSEcCtD
Silodosin—Dermatitis—Pravastatin—atherosclerosis	0.000418	0.00385	CcSEcCtD
Silodosin—Headache—Pravastatin—atherosclerosis	0.000415	0.00383	CcSEcCtD
Silodosin—Nausea—Niacin—atherosclerosis	0.0004	0.00369	CcSEcCtD
Silodosin—Nausea—Pravastatin—atherosclerosis	0.000394	0.00363	CcSEcCtD
Silodosin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.98e-05	0.000165	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA2—atherosclerosis	1.98e-05	0.000165	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	1.97e-05	0.000165	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KNG1—atherosclerosis	1.97e-05	0.000165	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGTR1—atherosclerosis	1.96e-05	0.000164	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	1.96e-05	0.000163	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ABCG5—atherosclerosis	1.95e-05	0.000163	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VWF—atherosclerosis	1.95e-05	0.000163	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	1.94e-05	0.000162	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.94e-05	0.000162	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.94e-05	0.000162	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	1.94e-05	0.000162	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	1.93e-05	0.000161	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CCL2—atherosclerosis	1.92e-05	0.000161	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	1.91e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	1.91e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PLG—atherosclerosis	1.91e-05	0.00016	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	1.91e-05	0.000159	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.91e-05	0.000159	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	1.9e-05	0.000158	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	1.89e-05	0.000158	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LPA—atherosclerosis	1.88e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	1.88e-05	0.000157	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	1.87e-05	0.000156	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	1.87e-05	0.000156	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	1.87e-05	0.000156	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CG—atherosclerosis	1.85e-05	0.000155	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BGN—atherosclerosis	1.83e-05	0.000152	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SOCS3—atherosclerosis	1.81e-05	0.000151	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA5—atherosclerosis	1.81e-05	0.000151	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	1.8e-05	0.00015	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—F2—atherosclerosis	1.79e-05	0.00015	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPARG—atherosclerosis	1.79e-05	0.000149	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—INS—atherosclerosis	1.76e-05	0.000147	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	1.75e-05	0.000146	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP3—atherosclerosis	1.75e-05	0.000146	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF2—atherosclerosis	1.74e-05	0.000145	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.74e-05	0.000145	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.72e-05	0.000144	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	1.72e-05	0.000144	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	1.71e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	1.7e-05	0.000142	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	1.7e-05	0.000142	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	1.69e-05	0.000141	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOB—atherosclerosis	1.69e-05	0.000141	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALOX5—atherosclerosis	1.68e-05	0.00014	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	1.68e-05	0.00014	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CXCL8—atherosclerosis	1.68e-05	0.00014	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EDN1—atherosclerosis	1.66e-05	0.000139	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	1.66e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	1.66e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	1.66e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCL5—atherosclerosis	1.65e-05	0.000138	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	1.64e-05	0.000137	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	1.63e-05	0.000136	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.62e-05	0.000135	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LPL—atherosclerosis	1.61e-05	0.000135	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ALB—atherosclerosis	1.61e-05	0.000134	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	1.6e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—F2—atherosclerosis	1.59e-05	0.000133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PLG—atherosclerosis	1.59e-05	0.000132	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRKCG—atherosclerosis	1.57e-05	0.000131	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NOS3—atherosclerosis	1.54e-05	0.000129	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.53e-05	0.000128	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SPP1—atherosclerosis	1.53e-05	0.000128	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	1.52e-05	0.000127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CXCL8—atherosclerosis	1.52e-05	0.000127	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NAMPT—atherosclerosis	1.51e-05	0.000126	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	1.5e-05	0.000125	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LIPC—atherosclerosis	1.5e-05	0.000125	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOC3—atherosclerosis	1.49e-05	0.000124	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LDLR—atherosclerosis	1.48e-05	0.000124	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	1.45e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	1.45e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	1.45e-05	0.000121	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CETP—atherosclerosis	1.44e-05	0.000121	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	1.44e-05	0.000121	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FABP4—atherosclerosis	1.44e-05	0.00012	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LCAT—atherosclerosis	1.44e-05	0.00012	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.42e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	1.42e-05	0.000118	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA4—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PLG—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—atherosclerosis	1.41e-05	0.000118	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOB—atherosclerosis	1.4e-05	0.000117	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.39e-05	0.000116	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SCARB1—atherosclerosis	1.38e-05	0.000116	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AGT—atherosclerosis	1.38e-05	0.000115	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	1.38e-05	0.000115	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	1.37e-05	0.000114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LEP—atherosclerosis	1.35e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOE—atherosclerosis	1.35e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	1.34e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LPL—atherosclerosis	1.34e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	1.34e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	1.33e-05	0.000111	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMGCR—atherosclerosis	1.31e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	1.3e-05	0.000109	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	1.29e-05	0.000108	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	1.29e-05	0.000108	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.28e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	1.28e-05	0.000107	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.28e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—F2—atherosclerosis	1.28e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	1.27e-05	0.000106	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	1.26e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOB—atherosclerosis	1.25e-05	0.000104	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	1.23e-05	0.000103	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	1.23e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA2—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	1.22e-05	0.000102	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.2e-05	0.0001	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LPL—atherosclerosis	1.19e-05	9.93e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	1.17e-05	9.8e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	1.17e-05	9.76e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ABCA1—atherosclerosis	1.16e-05	9.73e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPA—atherosclerosis	1.16e-05	9.7e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	1.16e-05	9.66e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—INS—atherosclerosis	1.16e-05	9.65e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGT—atherosclerosis	1.15e-05	9.57e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	1.14e-05	9.49e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	1.13e-05	9.41e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BGN—atherosclerosis	1.12e-05	9.39e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—atherosclerosis	1.12e-05	9.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—atherosclerosis	1.12e-05	9.37e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	1.12e-05	9.37e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	1.12e-05	9.33e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA5—atherosclerosis	1.11e-05	9.3e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	1.11e-05	9.29e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	1.11e-05	9.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.07e-05	8.95e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	1.07e-05	8.95e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	1.06e-05	8.86e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—F2—atherosclerosis	1.06e-05	8.84e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	1.04e-05	8.7e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.04e-05	8.65e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGT—atherosclerosis	1.02e-05	8.5e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	1.01e-05	8.46e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	1.01e-05	8.46e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—atherosclerosis	9.99e-06	8.34e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—atherosclerosis	9.97e-06	8.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—atherosclerosis	9.97e-06	8.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	9.88e-06	8.25e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	9.85e-06	8.23e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	9.7e-06	8.1e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—INS—atherosclerosis	9.59e-06	8.01e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOB—atherosclerosis	9.57e-06	7.99e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	9.52e-06	7.95e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	9.43e-06	7.88e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—F2—atherosclerosis	9.4e-06	7.85e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTM1—atherosclerosis	9.31e-06	7.78e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.28e-06	7.75e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	9.27e-06	7.75e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LIPC—atherosclerosis	9.23e-06	7.71e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOC3—atherosclerosis	9.17e-06	7.66e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LPL—atherosclerosis	9.14e-06	7.63e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LDLR—atherosclerosis	9.11e-06	7.61e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	9e-06	7.51e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	8.99e-06	7.51e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—atherosclerosis	8.92e-06	7.45e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CETP—atherosclerosis	8.9e-06	7.43e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	8.81e-06	7.36e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD36—atherosclerosis	8.68e-06	7.25e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	8.68e-06	7.25e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	8.62e-06	7.2e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	8.54e-06	7.14e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.52e-06	7.12e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—INS—atherosclerosis	8.52e-06	7.11e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	8.41e-06	7.02e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	8.38e-06	7e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	8.24e-06	6.88e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—atherosclerosis	8.23e-06	6.87e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	8.13e-06	6.79e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARA—atherosclerosis	8.07e-06	6.74e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.05e-06	6.72e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	8.04e-06	6.72e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	7.9e-06	6.6e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	7.88e-06	6.58e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	7.82e-06	6.53e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGT—atherosclerosis	7.82e-06	6.53e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—atherosclerosis	7.66e-06	6.4e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAV1—atherosclerosis	7.59e-06	6.34e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA1—atherosclerosis	7.57e-06	6.32e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	7.47e-06	6.24e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	7.46e-06	6.23e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	7.3e-06	6.1e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	7.23e-06	6.04e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	7.2e-06	6.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.17e-06	5.99e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	7.09e-06	5.92e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—atherosclerosis	7.08e-06	5.91e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.91e-06	5.77e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	6.9e-06	5.77e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	6.75e-06	5.63e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	6.7e-06	5.59e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	6.67e-06	5.57e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—atherosclerosis	6.67e-06	5.57e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	6.62e-06	5.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	6.56e-06	5.48e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—INS—atherosclerosis	6.54e-06	5.47e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	6.54e-06	5.46e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	6.4e-06	5.35e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.3e-06	5.26e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.16e-06	5.14e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	6.06e-06	5.06e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—atherosclerosis	6e-06	5.01e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	6e-06	5.01e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	5.99e-06	5e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	5.93e-06	4.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOB—atherosclerosis	5.9e-06	4.92e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	5.83e-06	4.87e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	5.81e-06	4.85e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—atherosclerosis	5.74e-06	4.79e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.74e-06	4.79e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	5.73e-06	4.79e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPL—atherosclerosis	5.63e-06	4.7e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	5.56e-06	4.64e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—atherosclerosis	5.49e-06	4.59e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.38e-06	4.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD36—atherosclerosis	5.35e-06	4.47e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.33e-06	4.45e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—atherosclerosis	5.25e-06	4.38e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.09e-06	4.25e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.07e-06	4.23e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—atherosclerosis	5.05e-06	4.22e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARA—atherosclerosis	4.97e-06	4.15e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	4.94e-06	4.12e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGT—atherosclerosis	4.82e-06	4.02e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—atherosclerosis	4.72e-06	3.94e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAV1—atherosclerosis	4.68e-06	3.91e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA1—atherosclerosis	4.67e-06	3.9e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	4.66e-06	3.89e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.26e-06	3.56e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—atherosclerosis	4.19e-06	3.5e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—atherosclerosis	4.11e-06	3.43e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—INS—atherosclerosis	4.03e-06	3.37e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	3.86e-06	3.23e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	3.72e-06	3.11e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—atherosclerosis	3.7e-06	3.09e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—atherosclerosis	3.54e-06	2.95e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.43e-06	2.87e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.23e-06	2.7e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—atherosclerosis	2.64e-06	2.2e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—atherosclerosis	1.63e-06	1.36e-05	CbGpPWpGaD
